Health Catalyst, Inc.
HCAT
$3.38
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.65% | -0.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.65% | -0.24% | |||
| Cost of Revenue | 1.59% | -7.05% | |||
| Gross Profit | 1.71% | 8.49% | |||
| SG&A Expenses | -0.99% | 5.08% | |||
| Depreciation & Amortization | 2.95% | 20.01% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.66% | -1.50% | |||
| Operating Income | 14.14% | 8.27% | |||
| Income Before Tax | -73.83% | -17.35% | |||
| Income Tax Expenses | -62.33% | -65.60% | |||
| Earnings from Continuing Operations | -72.60% | -14.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -72.60% | -14.85% | |||
| EBIT | 14.14% | 8.27% | |||
| EBITDA | 52.47% | 40.88% | |||
| EPS Basic | -69.94% | -4.50% | |||
| Normalized Basic EPS | 10.10% | 11.21% | |||
| EPS Diluted | -69.94% | -4.50% | |||
| Normalized Diluted EPS | 10.10% | 11.21% | |||
| Average Basic Shares Outstanding | 1.57% | 9.90% | |||
| Average Diluted Shares Outstanding | 1.57% | 9.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||